Maeda M, Kawasaki K, Takahashi M, Nakao K, Kaneto H
Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Japan.
Chem Pharm Bull (Tokyo). 1994 Sep;42(9):1859-63. doi: 10.1248/cpb.42.1859.
Hybrids of amino-poly(ethylene glycol) (aPEG) and [D-Ala2,(N-Me)Phe4] enkephalin analogs, H-Tyr-D-Ala-Gly-(Me)Phe-aPEG, H-Tyr-D-Ala-Gly-(Me)Phe-Leu-aPEG and H-Tyr-D-Ala-Gly-(Me)Phe-D-Leu-aPEG, were prepared by the solution method and their antinociceptive properties were examined in comparison with those of the peptides. H-Tyr-D-Ala-Gly-(Me)Phe-OH and H-Tyr-D-Ala-Gly-(Me)Phe-Leu-OH themselves at intracerebroventricular (i.c.v.) doses of 10-30 nmol/animal produced an antinociceptive effect which was less potent than that of i.c.v. morphine, 3 micrograms/animal, and H-Tyr-D-Ala-Gly-(Me)Phe-D-Leu-OH did not have any marked effect. However, the antinociceptive effects of H-Tyr-D-Ala-Gly-(Me)Phe-Leu-OH and H-Tyr-D-Ala-Gly-(Me)Phe-D-Leu-OH were remarkably potentiated by hybrid formation with aPEG to levels higher than that of 3 micrograms/mouse of morphine, and the effect lasted at least 120 min. In contrast, the effect of H-Tyr-D-Ala-Gly-(Me)Phe-OH was rather diminished by hybrid formation. In view of the low toxicity and weak immunogenic properties of aPEG, the hybrids could be useful in therapy of patients for relieving chronic and severe pain.
通过溶液法制备了氨基聚乙二醇(aPEG)与[D-Ala2,(N-Me)Phe4]脑啡肽类似物H-Tyr-D-Ala-Gly-(Me)Phe-aPEG、H-Tyr-D-Ala-Gly-(Me)Phe-Leu-aPEG和H-Tyr-D-Ala-Gly-(Me)Phe-D-Leu-aPEG的杂合物,并与肽类的抗伤害感受特性进行了比较研究。脑室内(i.c.v.)给予剂量为10-30 nmol/动物的H-Tyr-D-Ala-Gly-(Me)Phe-OH和H-Tyr-D-Ala-Gly-(Me)Phe-Leu-OH本身产生的抗伤害感受作用比脑室内给予3μg/动物的吗啡弱,而H-Tyr-D-Ala-Gly-(Me)Phe-D-Leu-OH没有任何明显作用。然而,通过与aPEG形成杂合物,H-Tyr-D-Ala-Gly-(Me)Phe-Leu-OH和H-Tyr-D-Ala-Gly-(Me)Phe-D-Leu-OH的抗伤害感受作用显著增强,达到高于3μg/小鼠吗啡的水平,且该作用至少持续120分钟。相反,杂合物形成使H-Tyr-D-Ala-Gly-(Me)Phe-OH的作用有所减弱。鉴于aPEG的低毒性和弱免疫原性,这些杂合物可能对缓解慢性和重度疼痛的患者治疗有用。